> Products > Ectoine API

China Ectoine API Factory

Our business has been focusing on brand strategy. Customers' pleasure is our best advertising. We also offer OEM company for Ectoine API,CAS NO 96702-03-3,96702-03-3,Ectoine, Our main objectives are to provide our customers worldwide with good quality, competitive price, satisfied delivery and excellent services.
Ectoine API, Our company now has many department, and there have more than 20 employees in our company. We set up sales shop, show room, and product warehouse. In the meantime, we registered our own brand. We have tightened inspection for quality of product.

Hot Products

Levodopa
Product Name:Levodopa
Molecular Formula:C9H11NO4
Molecular Weight;197.19
CAS Registry Number;59-92-7
Spironolactone
Product Name:Spironolactone
Molecular Formula:C24H32O4S
Molecular Weight;416.58
CAS Registry Number;52-01-7
4-(4-Chlorobutyl)Pyridine Hydrochloride
Product Name:4-(4-Chlorobutyl)Pyridine Hydrochloride
Molecular Formula:C9H12ClN.HCl
Molecular Weight:206.11
CAS NO:149463-65-0
Usage:Tirofiban Hydrochloride
Methyl 4-(acetylaMino)-3-broMo-5-chloro-2-hydroxybenzoate
Product Name:Methyl 4-(acetylaMino)-3-broMo-5-chloro-2-hydroxybenzoate
Molecular Formula:C10H9BrClNO4
Molecular Weight:322.54
CAS Registry Number:232941-14-9
2,5-DIFLUOROANISOLE
Product Name:2,5-DIFLUOROANISOLE
Molecular Formula:C7H6F2O
Molecular Weight:144.12
CAS Registry Number:75626-17-4
PRASEODYMIUM CHLORIDE
Product Name:PRASEODYMIUM CHLORIDE
Molecular Formula:Cl3Pr
Molecular Weight:247.27
CAS Registry Number:10361-79-2

Related Blog
Reviews

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Why API manufacturing companies almostly in China?
In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...
Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS
Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...
Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry
Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...
Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates
In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

China Ectoine API Factory

Related Products

Hot Products

Levodopa

Spironolactone

4-(4-Chlorobutyl)Pyridine Hydrochloride

Methyl 4-(acetylaMino)-3-broMo-5-chloro-2-hydroxybenzoate

2,5-DIFLUOROANISOLE

PRASEODYMIUM CHLORIDE

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Why API manufacturing companies almostly in China?

Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

Doris 2023-05-20 13:02:56

Hedy 2022-12-14 00:33:41

Freda 2023-05-14 08:32:34

Jill 2023-06-17 16:54:18

Mag 2023-12-03 12:08:05

Jean Ascher 2022-04-22 22:08:06

Send Inquiry